Abstract
Aging affects multiple organs and systems, which become unable to respond to stressors and environmental changes and therefore deteriorate in terms of function and structure.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Cevenini E, Invidia L, Lescai F, et al. Human models of aging and longevity. Expert Opin Biol Ther. 2008;8:1393-1405.
Duque G, Troen BR. Understanding the mechanisms of senile osteoporosis: new facts for a major geriatric syndrome. J Am Geriatr Soc. 2008;56:935-941.
Manolagas SC, Parfitt AM. What old means to bone. Trends Endocrinol Metab. 2010;21:369-374.
Lelovas PP, Xanthos TT, Thoma SE, et al. The laboratory rat as an animal model for osteoporosis research. Comp Med. 2008;58:424-430.
Perel P, Roberts I, Sena E, et al. Comparison of treatment effects between animal experiments and clinical trials: systematic review. BMJ. 2007;334:197.
Lyritis GP, Georgoulas T, Zafeiris CP. Bone anabolic versus bone anticatabolic treatment of postmenopausal osteoporosis. Ann NY Acad Sci. 2010;1205:277-283.
Burtner CR, Kennedy BK. Progeria syndromes and ageing: what is the connection? Nat Rev Mol Cell Biol. 2010;11:567-578.
Osorio FG, Obaya AJ, López-Otín C, et al. Accelerated ageing: from mechanism to therapy through animal models. Transgenic Res. 2009;18:7-15.
Cox LS, Faragher RG. From old organisms to new molecules: integrative biology and therapeutic targets in accelerated human ageing. Cell Mol Life Sci. 2007;64:2620-2641.
Yu CE, Oshima J, Fu YH, et al. Positional cloning of the Werner’s syndrome gene. Science. 1996;272:258-262.
Lombard DB, Beard C, Johnson B, et al. Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Mol Cell Biol. 2000;20:3286-3291.
Chang S, Multani AS, Cabrera NG, et al. Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat Genet. 2004;36:877-882.
Multani AS, Chang S. WRN at telomeres: implications for aging and cancer. J Cell Sci. 2007;120:713-721.
Lavin MF, Shiloh Y. The genetic defect in ataxia-telangiectasia. Annu Rev Immunol. 1997;15:177-202.
Rotman G, Shiloh Y. ATM: from gene to function. Hum Mol Genet. 1998;7:1555-1563.
Barlow C, Hirotsune S, Paylor R, et al. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell. 1996;86:159-171.
Hennekam RC. Hutchinson-Gilford progeria syndrome: review of the phenotype. Am J Med Genet A. 2006;140:2603-2624.
Merideth MA, Gordon LB, Clauss S, et al. Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med. 2008;358:592-604.
Pereira S, Bourgeois P, Navarro C, et al. HGPS and related premature aging disorders: from genomic identification to the first therapeutic approaches. Mech Ageing Dev. 2008; 129:449-459.
de Paula Rodrigues GH, das Eiras Tâmega I, et al. Severe bone changes in a case of Hutchinson-Gilford syndrome. Ann Genet. 2002;45:151-155.
De Sandre-Giovannoli A, Bernard R, Cau P, et al. Lamin A truncation in Hutchinson-Gilford progeria. Science. 2003; 300:2055.
Eriksson M, Brown WT, Gordon LB, et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature. 2003;423:293-298.
Pendas AM, Zhou Z, Cadinanos J, et al. Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat Genet. 2002;31:94-99.
Cadinanos J, Varela I, Lopez-Otin C, et al. From immature lamin to premature aging: molecular pathways and therapeutic opportunities. Cell Cycle. 2005;4:1732-1735.
de Carlos F, Varela I, Germana A, et al. Microcephalia with mandibular and dental dysplasia in adult Zmpste24 deficient mice. J Anat. 2008;213:509-519.
Varela I, Cadinanos J, Pendas AM, et al. Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature. 2005;437:564-568.
Fong LG, Ng JK, Meta M, et al. Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice. Proc Natl Acad Sci USA. 2004; 101:18111-18116.
Fong LG, Frost D, Meta M, et al. A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria. Science. 2006;311:1621-1623.
Sullivan T, Escalante-Alcalde D, Bhatt H, et al. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol. 1999; 147:913-920.
Opresko PL. Telomere ResQue and preservation–roles for the Werner syndrome protein and other RecQ helicases. Mech Ageing Dev. 2008;129:79-90.
Pignolo RJ, Suda RK, McMillan EA, et al. Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosis. Aging Cell. 2008;7:23-31.
Du X, Shen J, Kugan N, et al. Telomere shortening exposes functions for the mouse Werner and Bloom syndrome genes. Mol Cell Biol. 2004;24:8437-8446.
Lebel M, Spillare EA, Harris CC, et al. The Werner syndrome gene product co-purifies with the DNA replication complex and interacts with PCNA and topoisomerase I. J Biol Chem. 1999;274:37795-37799.
Akter R, Rivas D, Geneau G, et al. Effect of lamin A/C knockdown on osteoblast differentiation and function. J Bone Miner Res. 2009;24:283-293.
Duque G, Vidal C, Rivas D. Protein isoprenylation regulates osteogenic differentiation of mesenchymal stem cells: effect of alendronate, and farnesyl and geranylgeranyl transferase inhibitors. Br J Pharmacol. 2011;162:1109-1118.
Bergo MO, Gavino B, Ross J, et al. Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proc Natl Acad Sci USA. 2002;99:13049-13054.
Rivas D, Li W, Akter R, et al. Accelerated features of age-related bone loss in zmpste24 metalloproteinase-deficient mice. J Gerontol A Biol Sci Med Sci. 2009;64:1015-1024.
Ng A, Duque G. Osteoporosis as a lipotoxic disease. IBMS BoneKEy. 2010;7:108-123.
Varela I, Pereira S, Ugalde AP, et al. Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging. Nat Med. 2008;14:767-772.
Fatkin D, MacRae C, Sasaki T, et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med. 1999;341:1715-1724.
Chandar S, Yeo LS, Leimena C, et al. Effects of mechanical stress and carvedilol in lamin A/C-deficient dilated cardiomyopathy. Circ Res. 2010;106:573-582.
Li W, Yeo LS, Vidal C, McCorquodale T, Herrmann M, et al. 2011 Decreased Bone Formation and Osteopenia in Lamin A/C-Deficient Mice. PLoS ONE 6(4): e19313. doi:10.1371/journal.pone.0019313.
Duque G, Li W, Yeo L, et al. Exercise has a deleterious effect on bone quality in lamin A/C happloinsuficient mice.Bone, 2011 (in press).
Hishiya A, Ito M, Aburatani H, et al. Ataxia telangiectasia mutated (Atm) knockout mice as a model of osteopenia due to impaired bone formation. Bone. 2005;37:497-503.
Acknowledgments
The experimental results reported in this chapter were obtained thanks to the support of the Australian National Health and Medical Research Council (NHMRC) and the Nepean Medical Research Foundation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag London Limited
About this chapter
Cite this chapter
Li, W., Duque, G. (2011). Animal Models of Premature Aging. In: Duque, G., Watanabe, K. (eds) Osteoporosis Research. Springer, London. https://doi.org/10.1007/978-0-85729-293-3_11
Download citation
DOI: https://doi.org/10.1007/978-0-85729-293-3_11
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-292-6
Online ISBN: 978-0-85729-293-3
eBook Packages: MedicineMedicine (R0)